Valuation: Formycon AG

Market Cap 334M 374M 312M 283M 533M 36.16B 537M 3.74B 1.46B 18.39B 1.4B 1.37B 59.12B P/E 2026 *
630x
P/E 2027 * 14.2x
Enterprise Value 448M 502M 418M 380M 715M 48.53B 721M 5.03B 1.96B 24.68B 1.88B 1.84B 79.34B EV / Sales 2026 *
6.17x
EV / Sales 2027 * 3.98x
Free-Float
70%
Yield 2026 *
-
Yield 2027 * -
1 day-0.21%
1 week-2.28%
Current month-2.28%
1 month-7.58%
3 months+1.07%
6 months+6.42%
Current year-26.17%
1 week 18.3
Extreme 18.3
20
1 month 18.3
Extreme 18.3
20.75
Current year 15.8
Extreme 15.8
26.95
1 year 15.8
Extreme 15.8
26.95
3 years 15.8
Extreme 15.8
67.8
5 years 15.8
Extreme 15.8
94.1
10 years 14.65
Extreme 14.65
94.1
Manager TitleAgeSince
Chief Executive Officer - 2022-06-30
Director of Finance/CFO 57 2023-03-31
Chief Tech/Sci/R&D Officer - 2022-06-30
Director TitleAgeSince
Director/Board Member 49 2020-12-09
Chairman 54 2024-06-11
Director/Board Member 54 2024-06-11
Date Insider Type Main position Quantity % Market Cap. Importance
2/21/25 Buy

Chief Technology Officer

160 0.0009%
4/29/24 Buy

Executive/Senior Manager

1,200 0.0068%
4/24/24 Buy

Chief Executive Officer

2,500 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
-0.21%-2.28%-25.59%-64.20% 377M
+4.16%+4.16%+49.37%+94.17% 74.69B
+0.46%-0.97%+23.51%+79.34% 58.81B
+0.17%+0.35%+6.85%+34.55% 48.45B
+0.50%-2.14%+331.33%+702.20% 42.84B
-0.72%-3.99%+28.50%+29.94% 42.79B
+0.34%-0.52%+6.56%+109.35% 41.25B
-0.11%+1.96%+9.19%+52.66% 31.13B
-0.88%+0.18%+33.69%+25.06% 30.28B
-0.50%-3.10%-10.19%-14.35% 24.05B
Average +0.31%-0.45%+45.32%+104.87% 39.47B
Weighted average by Cap. +0.77%-0.50%+56.09%+129.92%

Financials

2026 *2027 *
Net sales 72.66M 81.32M 67.79M 61.57M 116M 7.87B 117M 815M 318M 4B 305M 299M 12.86B 112M 126M 105M 95.23M 179M 12.17B 181M 1.26B 492M 6.19B 472M 462M 19.89B
Net income 343K 384K 320K 291K 547K 37.14M 552K 3.85M 1.5M 18.89M 1.44M 1.41M 60.71M 23.19M 25.95M 21.64M 19.65M 37.01M 2.51B 37.29M 260M 102M 1.28B 97.44M 95.33M 4.1B
Net Debt 114M 128M 107M 96.77M 182M 12.36B 184M 1.28B 500M 6.29B 480M 469M 20.21B 113M 127M 106M 96.1M 181M 12.28B 182M 1.27B 497M 6.24B 476M 466M 20.07B
Projected Income Statement - Annual - Formycon AG
Logo Formycon AG
Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.
Employees
196
Date Price Change Volume
26-10-07 €18.90 -0.21% 3,398
26-10-06 €18.94 -0.84% 2,958
26-10-05 €19.10 +4.37% 9,744
26-10-02 €18.30 -7.29% 6,829
26-10-01 €19.74 +2.07% 1,886
Trader
Investor
-
Global
-
Quality
ESG MSCI
B
Ratings Surperformance© - Formycon AG
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
18.90EUR
Average target price
39.67EUR
Spread / Average Target
+109.88%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Formycon AG